Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction
NCT ID: NCT06038994
Last Updated: 2023-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2023-09-01
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction
NCT04485988
Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
NCT02641184
Using Higher Cut-off Values to Diagnose Acute Myocardial Infarction in Patients With Elevated Hs-cTnT Concentrations
NCT06059079
Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction
NCT04871126
Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment
NCT03297164
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with acute myocardial infarction who experienced CAG
Patients with acute myocardial infarction who experienced coronary angiography
No intervention
This is an obvertional study, and there is no intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
This is an obvertional study, and there is no intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. patients received coronary angiography
3. invasive management within 72 h of hospital admission
Exclusion Criteria
2. malignant tumor
3. acute infection
4. thyroid dysfunction
5. Life expectancy of b1 y
6. Unsuitable for PCI
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jin Geng
associate doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shuren Ma, MD.
Role: PRINCIPAL_INVESTIGATOR
NJMU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huai'an First People's Hospital
Huai'an, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xiaozhong Yang, MD.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20230901
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.